AMFR antibody (C-Term)
-
- Target See all AMFR Antibodies
- AMFR (Autocrine Motility Factor Receptor (AMFR))
-
Binding Specificity
- C-Term
-
Reactivity
- Human, Mouse, Rat, Dog
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This AMFR antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- AMFR antibody was raised against the C terminal of AMFR
- Purification
- Purified
- Immunogen
- AMFR antibody was raised using the C terminal of AMFR corresponding to a region with amino acids FGEVEVEPSEVEDFEARGSRFSKSADERQRMLVQRKDELLQQARKRFLNK
- Top Product
- Discover our top product AMFR Primary Antibody
-
-
- Application Notes
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
AMFR Blocking Peptide, catalog no. 33R-2901, is also available for use as a blocking control in assays to test for specificity of this AMFR antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of AMFR antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- AMFR (Autocrine Motility Factor Receptor (AMFR))
- Alternative Name
- AMFR (AMFR Products)
- Background
- Autocrine motility factor is a tumor motility-stimulating protein secreted by tumor cells. AMFR is a glycosylated transmembrane protein and a receptor for autocrine motility factor. The receptor, which shows some sequence similarity to tumor protein p53, is localized to the leading and trailing edges of carcinoma cells.
- Molecular Weight
- 53 kDa (MW of target protein)
- Pathways
- ER-Nucleus Signaling
-